Back to Search
ALFRED BURGER, MD
MD
Hospitalist Physician
NPI: 1972692374IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
227908(NY)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
227908(NY)
CMS Specialties
PrimaryHOSPITALIST
Education
OTHER
Class of 1999
Research & Publications (20)
A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.
PMID 16288031·Cancer Res·2005
8-other
The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
PMID 15735037·Cancer Res·2005
7-preclinical
Identification of homologues to the pathogenicity factor Pat-1, a putative serine protease of Clavibacter michiganensis subsp. michiganensis.
PMID 16255147·Microbiol Res·2005
8-other
17-(Allylamino)-17-demethoxygeldanamycin activity in human melanoma models.
PMID 15057143·Anticancer Drugs·2004
7-preclinical
The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications.
PMID 15454246·Eur J Cancer·2004
6-review
Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
PMID 11340578·Int J Cancer·2001
7-preclinical
Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro.
PMID 11642008·Arzneimittelforschung·2001
7-preclinical
Identification and characterization of the mre gene region of Streptomyces coelicolor A3(2).
PMID 10954092·Mol Gen Genet·2000
8-other
The tumor suppressor WTX shuttles to the nucleus and modulates WT1 activity.
PMID 19416806·Proc Natl Acad Sci U S A·2009
8-other
Phospho-p70S6K/p85S6K and cdc2/cdk1 are novel targets for diffuse large B-cell lymphoma combination therapy.
PMID 19223503·Clin Cancer Res·2009
8-other
Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
PMID 19225872·Pharm Res·2009
7-preclinical
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2.
PMID 19116989·J Pathol·2009
7-preclinical
Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma.
PMID 19671864·Clin Cancer Res·2009
3-trial
The relationship between body mass index and mortality in patients with acute decompensated heart failure.
PMID 18353454·Int J Cardiol·2009
8-other
EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
PMID 18852121·Mol Cancer Ther·2008
7-preclinical
17alpha-Hydroxylase/17,20 lyase inhibitor VN/124-1 inhibits growth of androgen-independent prostate cancer cells via induction of the endoplasmic reticulum stress response.
PMID 18790763·Mol Cancer Ther·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 350 E 17TH ST, BETH ISRAEL MEDICAL CENTER
NEW YORK, NY 10003 - Phone
- (212) 420-2690
Quick Facts
- NPI
- 1972692374
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile